Susan E. Yost

Also affiliated with City of Hope

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.114Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer institute

PLoS ONE(2023)10.1371/journal.pone.0286998

Top 72%

0.114DataRank

Top 72%1 citations

Susan Shehayeb, Nicole Lugo Santiago, Laura Kruper, Ernest Han, Edward Wang +5 more

Papers

Driven by 24 papers — median percentile 28. Top paper: “Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer”.

Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002084

N/A

1.3DataRank · unranked

32 citations

Weihua Guo, Susan E. Yost, Jin Sun Lee, D. L. ROSE, Christian Avalos +7 more

Analysis of Gut Microbiome Using Explainable Machine Learning Predicts Risk of Diarrhea Associated With Tyrosine Kinase Inhibitor Neratinib: A Pilot Study

Frontiers in Oncology(2021)10.3389/fonc.2021.604584

N/A

1.0DataRank · unranked

32 citations

Susan E. Yost, Jin Sun Lee, John D. Gillece, Megan Folkerts, Lauren Reining +5 more

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03470-y

N/A

0.809DataRank · unranked

22 citations

Weihua Guo, Susan E. Yost, Xuan Ge, Jin Sun Lee, Paul Frankel +12 more

Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth

Nature Cell Biology(2022)10.1038/s41556-022-00919-7

N/A

0.735DataRank · unranked

133 citations

Roi Isaac, Wei Yan, Xianhui Ruan, Li Jiang, Yuhao Wan +24 more

Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer

The Oncologist(2023)10.1093/oncolo/oyad026

N/A

0.580DataRank · unranked

14 citations

Susan E. Yost, Yujie Cui, Christopher Ruel, Mireya Murga, Aileen Tang +10 more

Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer

Journal of Geriatric Oncology(2021)10.1016/j.jgo.2021.02.020

N/A

0.430DataRank · unranked

7 citations

Jin Sun Lee, Susan E. Yost, Tracey Stiller, M. Suzette Blanchard, Simran Padam +13 more

Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer

Cancers(2022)10.3390/cancers14174279

N/A

0.385DataRank · unranked

12 citations

Susan E. Yost, Jin Sun Lee, Paul Frankel, Christopher Ruel, Yujie Cui +13 more

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231210675

N/A

0.296DataRank · unranked

5 citations

Colt A. Egelston, Oscar Colunga Flores, Shyambabu Chaurasiya, David Pei‐Cheng Lin, Helen Chang +17 more

BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer institute

PLoS ONE(2023)10.1371/journal.pone.0286998

Top 72%

0.114DataRank

Top 72%1 citations

Susan Shehayeb, Nicole Lugo Santiago, Laura Kruper, Ernest Han, Edward Wang +5 more

937 Comprehensive immune profiling unravels evolution of spatial distribution and immune repertoire in tumor microenvironment from primary to metastatic triple negative breast cancers

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0937

N/A

0DataRank · unranked

0 citations

Colt A. Egelston, Katherine E. Hutchinson, Jennifer M. Giltnane, Veronica Ibarra, Bonnie Liu +4 more

Clinical Actionability of Molecular Targets in Multi-Ethnic Breast Cancer Patients: A Retrospective Single-Institutional Study

Molecular Diagnosis & Therapy(2025)10.1007/s40291-025-00777-7

N/A

0DataRank · unranked

7 citations

Leah Naghi, Susan E. Yost, Joanne Mortimer, Irene Kang

Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial

Annals of Surgical Oncology(2025)10.1245/s10434-025-18432-0

N/A

0DataRank · unranked

4 citations

Rosemary Senguttuvan, Nora Ruel, Paul Frankel, Susan E. Yost, Sarah Cole +16 more

The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate

Antioxidants(2025)10.3390/antiox14030345

N/A

0DataRank · unranked

7 citations

Hyejin Cho, Xiwei Wu, Paul Frankel, Nora Ruel, Susan E. Yost +14 more

Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345

Antioxidants(2025)10.3390/antiox14121479

N/A

0DataRank · unranked

0 citations

Hyejin Cho, Xiwei Wu, Paul Frankel, Nora Ruel, Susan E. Yost +14 more

Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer

The Oncologist(2020)10.1002/onco.13574

N/A

0DataRank · unranked

43 citations

Jin Sun Lee, Susan E. Yost, Sierra Min Li, Paul Frankel, Christopher Ruel +17 more

Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progress

Pleura and Peritoneum(2025)10.1515/pp-2025-0036

N/A

0DataRank · unranked

0 citations

Paul H. Frankel, Nora H. Ruel, Susan E. Yost, Sue Chang, Edward Wang +12 more

Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis

PLoS ONE(2020)10.1371/journal.pone.0229955

N/A

0DataRank · unranked

33 citations

Susan E. Yost, Paul Frankel, Andrew Dagis, Yu Cao, Roger Wang +8 more

Co-stimulatory and co-inhibitory Immune Markers in Solid Tumors With MET Alterations

Future Science OA(2020)10.2144/fsoa-2020-0159

N/A

0DataRank · unranked

2 citations

Jasmine A. McQuerry, Isa Mambetsariev, Rebecca Pharaon, Susan E. Yost, Jeremy Fricke +14 more

Metabolic syndrome risk components and mortality after triple‐negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative

Cancer(2021)10.1002/cncr.33407

N/A

0DataRank · unranked

6 citations

Kathy Pan, Joanne Mortimer, Rowan T. Chlebowski, Juhua Luo, Jessica Yan +12 more

Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.19.456799

N/A

0DataRank · unranked

0 citations

Kalyan Banda, Pooja Kumar, Robert F. Straub, Lacey E. Dobrolecki, Isabel V. Rodriguez +10 more

Predicting hyperglycemia among patients receiving alpelisib plus fulvestrant for metastatic breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1060

N/A

0DataRank · unranked

2 citations

Carolyn E. Behrendt, Susan E. Yost, Niki Patel, Raynald Samoa, Daphne Stewart +6 more

Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer

Journal of Clinical Medicine(2023)10.3390/jcm12051906

N/A

0DataRank · unranked

4 citations

Sayeh Lavasani, Leon Cristobal, Niki Tank Patel, Mina S. Sedrak, Daphne Stewart +10 more

Medication-Related Osteonecrosis of the Jaw: Successful Medical Management of Complex Maxillary Alveolus with Sinus Involvement

Case Reports in Oncology(2023)10.1159/000529502

N/A

0DataRank · unranked

11 citations

Praveen Arany, Susan E. Yost, Yuan Yuan, Joel B. Epstein

Oral Chronic Graft-versus-Host Disease in Post-Hematopoietic Stem Cell Transplant Patients Following SARS-CoV-2 Vaccination: Case Reports

Case Reports in Oncology(2023)10.1159/000533821

N/A

0DataRank · unranked

2 citations

Raymond S Hernandez, Ryotaro Nakamura, Susan E. Yost, Haris Ali, Joel B. Epstein

Susan E. Yost

Indexed papers

Top data-sharing exemplar

Papers